Shigeki Momohara

TL;DR: Interim analyses of AEs during the initial 6-month treatment period from PMS reports of tofacitinib in Japanese patients did not reveal any new or unexpected safety signals vs the tofacItinib RA clinical programme.

TL;DR: The recent implementation of medical therapy in RA patients may have suppressed and delayed the progression of destruction in arthritic joints, thereby resulting in postponement of surgery, and clinical results provide evidence that recently introduced medical therapies result in better long-term outcomes for RA patients.

TL;DR: Higher HAQ and m TSS at baseline inhibits HAQ-DI improvement within 1 year of etanercept treatment, and the cutoff point necessary for mTSS to improve physical functions in patients with RA was 55.5.

TL;DR: In this paper, a neglected spontaneous rupture of the Achilles tendon in 5 elderly rheumatoid arthritis patients with corticosteroids for a long time was reported, and they did not show any signs, such as click or impact on the rear foot at the moment of the rupture, and had few complaints or obvious symptoms around their ankles or the rear of the foot after the rupture.

TL;DR: C-reactive protein levels and counts of swollen joints would be useful measures of the effectiveness of the interleukin-12/23 monoclonal antibody in preventing the development of skin lesions and arthritis in patients with psoriasis.